Article Details

CGRP Monoclonal Antibodies Show No Significant Impact on Persistent Headaches in ...

Retrieved on: 2022-06-13 21:25:54

Tags for this article:

Click the tags to see associated articles and topics

CGRP Monoclonal Antibodies Show No Significant Impact on Persistent Headaches in .... View article details on hiswai:

Excerpt

... the number of monthly headache days by at least 25%, 75%, or 100%, were also not significant following treatment with CGRP monoclonal antibodies.

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up